Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Body Temperature | 2 | 2022 | 125 | 0.850 |
Why?
|
Heat Stroke | 4 | 2023 | 9 | 0.830 |
Why?
|
Bioterrorism | 5 | 2007 | 18 | 0.820 |
Why?
|
Epilepsy | 8 | 2023 | 424 | 0.820 |
Why?
|
Anthrax | 5 | 2007 | 30 | 0.810 |
Why?
|
Anticonvulsants | 8 | 2021 | 125 | 0.810 |
Why?
|
Telemetry | 1 | 2022 | 36 | 0.810 |
Why?
|
Epilepsies, Partial | 5 | 2023 | 42 | 0.790 |
Why?
|
Patient Satisfaction | 4 | 2001 | 461 | 0.530 |
Why?
|
Epilepsy, Reflex | 3 | 2015 | 7 | 0.480 |
Why?
|
Heat Stress Disorders | 2 | 2022 | 12 | 0.410 |
Why?
|
Bacillus anthracis | 2 | 2003 | 73 | 0.400 |
Why?
|
Emergency Service, Hospital | 5 | 2007 | 521 | 0.380 |
Why?
|
Exercise | 3 | 2023 | 323 | 0.350 |
Why?
|
Inhalation Exposure | 2 | 2007 | 31 | 0.340 |
Why?
|
Inservice Training | 2 | 1999 | 38 | 0.320 |
Why?
|
Neurotensin | 2 | 2018 | 10 | 0.310 |
Why?
|
Intellectual Disability | 2 | 2021 | 189 | 0.310 |
Why?
|
Young Adult | 14 | 2023 | 6312 | 0.300 |
Why?
|
Facial Muscles | 2 | 2008 | 23 | 0.290 |
Why?
|
Drug Resistant Epilepsy | 2 | 2017 | 51 | 0.290 |
Why?
|
Respiratory Tract Infections | 3 | 2003 | 106 | 0.280 |
Why?
|
Acetamides | 2 | 2017 | 26 | 0.280 |
Why?
|
Hippocampus | 2 | 2017 | 447 | 0.280 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2006 | 2 | 0.280 |
Why?
|
Guidelines as Topic | 2 | 2007 | 160 | 0.270 |
Why?
|
Energy Metabolism | 2 | 2018 | 277 | 0.260 |
Why?
|
Disease Outbreaks | 2 | 2004 | 155 | 0.260 |
Why?
|
Spores, Bacterial | 2 | 2003 | 18 | 0.260 |
Why?
|
Hot Temperature | 3 | 2021 | 208 | 0.260 |
Why?
|
Adult | 19 | 2023 | 26607 | 0.240 |
Why?
|
Hypothermia | 1 | 2023 | 26 | 0.220 |
Why?
|
Adolescent | 12 | 2023 | 9263 | 0.220 |
Why?
|
Vancomycin | 1 | 2023 | 73 | 0.220 |
Why?
|
Virginia | 6 | 2019 | 16 | 0.220 |
Why?
|
Epilepsy, Generalized | 1 | 2023 | 40 | 0.220 |
Why?
|
Vigabatrin | 1 | 2002 | 3 | 0.220 |
Why?
|
Nipecotic Acids | 1 | 2002 | 5 | 0.220 |
Why?
|
Premedication | 1 | 2002 | 58 | 0.210 |
Why?
|
Hypercapnia | 1 | 2022 | 44 | 0.210 |
Why?
|
Capsules | 1 | 2022 | 37 | 0.210 |
Why?
|
Nursing Staff, Hospital | 2 | 1999 | 42 | 0.200 |
Why?
|
Hypothalamic Area, Lateral | 2 | 2018 | 11 | 0.200 |
Why?
|
Compassionate Use Trials | 1 | 2021 | 7 | 0.200 |
Why?
|
Mediastinal Diseases | 1 | 2001 | 22 | 0.200 |
Why?
|
Football | 1 | 2022 | 45 | 0.190 |
Why?
|
Carbon Dioxide | 1 | 2022 | 202 | 0.190 |
Why?
|
Running | 1 | 2021 | 25 | 0.190 |
Why?
|
Epilepsies, Myoclonic | 1 | 2021 | 18 | 0.190 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2001 | 75 | 0.180 |
Why?
|
Neurodevelopmental Disorders | 1 | 2021 | 44 | 0.180 |
Why?
|
Temperature | 1 | 2022 | 404 | 0.180 |
Why?
|
Seizures | 3 | 2023 | 306 | 0.180 |
Why?
|
Air Pressure | 1 | 2020 | 7 | 0.180 |
Why?
|
Patient Care | 1 | 2001 | 102 | 0.180 |
Why?
|
Leptin | 2 | 2018 | 102 | 0.180 |
Why?
|
Hand Strength | 1 | 2020 | 52 | 0.180 |
Why?
|
Humans | 29 | 2023 | 89349 | 0.180 |
Why?
|
Locomotion | 2 | 2018 | 138 | 0.180 |
Why?
|
Acclimatization | 1 | 2020 | 76 | 0.170 |
Why?
|
Neurons | 3 | 2018 | 1583 | 0.170 |
Why?
|
Emergency Nursing | 1 | 1999 | 7 | 0.170 |
Why?
|
Education, Nursing, Continuing | 1 | 1999 | 9 | 0.170 |
Why?
|
Electroencephalography | 4 | 2023 | 751 | 0.170 |
Why?
|
Patient Participation | 1 | 2001 | 224 | 0.170 |
Why?
|
Body Weight | 2 | 2018 | 452 | 0.170 |
Why?
|
Anesthesiology | 1 | 2001 | 162 | 0.160 |
Why?
|
Orexins | 1 | 2018 | 8 | 0.160 |
Why?
|
Hypothermia, Induced | 1 | 2019 | 82 | 0.160 |
Why?
|
Professional-Patient Relations | 1 | 1998 | 54 | 0.160 |
Why?
|
Adaptation, Psychological | 1 | 1999 | 166 | 0.160 |
Why?
|
Adiposity | 1 | 2018 | 76 | 0.150 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 30 | 0.150 |
Why?
|
Quality of Health Care | 1 | 2001 | 385 | 0.150 |
Why?
|
Male | 19 | 2023 | 42410 | 0.150 |
Why?
|
Malformations of Cortical Development | 1 | 2017 | 39 | 0.150 |
Why?
|
Retrospective Studies | 9 | 2023 | 9057 | 0.150 |
Why?
|
Receptors, Leptin | 1 | 2017 | 32 | 0.150 |
Why?
|
Ghrelin | 1 | 2017 | 29 | 0.140 |
Why?
|
Patient Education as Topic | 2 | 2016 | 360 | 0.140 |
Why?
|
Anxiety Disorders | 1 | 2017 | 152 | 0.140 |
Why?
|
Depressive Disorder | 1 | 2017 | 221 | 0.140 |
Why?
|
Death, Sudden | 1 | 2016 | 40 | 0.130 |
Why?
|
Feeding Behavior | 1 | 2018 | 327 | 0.130 |
Why?
|
Quality Assurance, Health Care | 2 | 1999 | 225 | 0.130 |
Why?
|
Child | 7 | 2021 | 7173 | 0.130 |
Why?
|
Single-Blind Method | 3 | 2022 | 150 | 0.130 |
Why?
|
Quinazolinones | 1 | 2015 | 15 | 0.130 |
Why?
|
Hypoxia | 1 | 2020 | 653 | 0.120 |
Why?
|
Counseling | 1 | 2016 | 164 | 0.120 |
Why?
|
Female | 15 | 2023 | 46200 | 0.120 |
Why?
|
Middle Aged | 12 | 2021 | 25974 | 0.110 |
Why?
|
Pyridones | 1 | 2014 | 56 | 0.110 |
Why?
|
Severity of Illness Index | 1 | 2019 | 1840 | 0.110 |
Why?
|
Delivery of Health Care | 1 | 2018 | 435 | 0.110 |
Why?
|
Personnel Management | 1 | 1992 | 7 | 0.110 |
Why?
|
Dioxolanes | 1 | 2012 | 8 | 0.110 |
Why?
|
Photic Stimulation | 1 | 2015 | 501 | 0.110 |
Why?
|
Germany | 3 | 2018 | 72 | 0.100 |
Why?
|
Postal Service | 2 | 2002 | 17 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2017 | 782 | 0.100 |
Why?
|
Drug Monitoring | 1 | 2012 | 119 | 0.100 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 645 | 0.090 |
Why?
|
Oxygen | 2 | 2022 | 743 | 0.090 |
Why?
|
Altitude Sickness | 2 | 2020 | 10 | 0.090 |
Why?
|
Child, Preschool | 4 | 2021 | 3731 | 0.090 |
Why?
|
Altitude | 2 | 2020 | 42 | 0.090 |
Why?
|
Mice | 5 | 2023 | 11761 | 0.090 |
Why?
|
Animals | 7 | 2023 | 27369 | 0.090 |
Why?
|
Models, Theoretical | 1 | 1992 | 491 | 0.080 |
Why?
|
Cytokines | 2 | 2023 | 803 | 0.080 |
Why?
|
Hospital-Patient Relations | 2 | 1999 | 2 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2017 | 784 | 0.080 |
Why?
|
Drug Synergism | 2 | 2015 | 306 | 0.080 |
Why?
|
Brain | 2 | 2017 | 2285 | 0.080 |
Why?
|
Comorbidity | 2 | 2017 | 949 | 0.080 |
Why?
|
Physicians | 1 | 2016 | 690 | 0.080 |
Why?
|
Treatment Outcome | 5 | 2021 | 8241 | 0.080 |
Why?
|
Pediatrics | 2 | 2016 | 353 | 0.080 |
Why?
|
Electromyography | 1 | 2008 | 193 | 0.080 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2008 | 202 | 0.070 |
Why?
|
Medical Audit | 1 | 2007 | 39 | 0.070 |
Why?
|
Biological Warfare | 2 | 2004 | 6 | 0.070 |
Why?
|
Age Factors | 3 | 2017 | 1870 | 0.070 |
Why?
|
Mouth | 1 | 2006 | 48 | 0.070 |
Why?
|
Videotape Recording | 1 | 2006 | 48 | 0.070 |
Why?
|
Triage | 1 | 2007 | 111 | 0.070 |
Why?
|
Evoked Potentials | 2 | 2008 | 190 | 0.070 |
Why?
|
Aged | 6 | 2021 | 19165 | 0.060 |
Why?
|
Austria | 2 | 2016 | 16 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 598 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 505 | 0.060 |
Why?
|
Public Health Practice | 1 | 2003 | 11 | 0.060 |
Why?
|
Survivors | 2 | 2002 | 234 | 0.050 |
Why?
|
Kindling, Neurologic | 1 | 2002 | 2 | 0.050 |
Why?
|
Culture Techniques | 1 | 2002 | 91 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2002 | 172 | 0.050 |
Why?
|
Physical Endurance | 1 | 2022 | 10 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 85 | 0.050 |
Why?
|
Chemokines | 1 | 2022 | 74 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 3218 | 0.050 |
Why?
|
Amino Acids | 1 | 2023 | 245 | 0.050 |
Why?
|
Magnesium | 1 | 2002 | 178 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 1242 | 0.050 |
Why?
|
Cohort Studies | 2 | 2022 | 2869 | 0.050 |
Why?
|
District of Columbia | 1 | 2001 | 20 | 0.050 |
Why?
|
Clindamycin | 1 | 2001 | 15 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 2001 | 36 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2001 | 29 | 0.050 |
Why?
|
Rifampin | 1 | 2001 | 23 | 0.050 |
Why?
|
Blood | 1 | 2001 | 69 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 1597 | 0.050 |
Why?
|
Fenfluramine | 1 | 2021 | 20 | 0.050 |
Why?
|
Pleural Effusion | 1 | 2001 | 48 | 0.050 |
Why?
|
Exercise Test | 1 | 2022 | 165 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2021 | 56 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2022 | 244 | 0.050 |
Why?
|
Epileptic Syndromes | 1 | 2021 | 8 | 0.050 |
Why?
|
Occupational Diseases | 1 | 2002 | 55 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2002 | 2661 | 0.050 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 8 | 0.050 |
Why?
|
Spasms, Infantile | 1 | 2021 | 35 | 0.050 |
Why?
|
Dyspnea | 1 | 2001 | 76 | 0.050 |
Why?
|
Karyotyping | 1 | 2021 | 253 | 0.050 |
Why?
|
Hospital Bed Capacity, 500 and over | 2 | 1998 | 5 | 0.050 |
Why?
|
Fever | 1 | 2001 | 128 | 0.050 |
Why?
|
Acetazolamide | 1 | 2020 | 10 | 0.050 |
Why?
|
Occupational Exposure | 1 | 2001 | 87 | 0.050 |
Why?
|
Anaerobic Threshold | 1 | 2020 | 4 | 0.050 |
Why?
|
Seasons | 1 | 2022 | 237 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2003 | 322 | 0.050 |
Why?
|
Intestines | 1 | 2023 | 416 | 0.040 |
Why?
|
Humidity | 1 | 2020 | 92 | 0.040 |
Why?
|
Mass Screening | 1 | 2004 | 636 | 0.040 |
Why?
|
Precipitating Factors | 1 | 2019 | 5 | 0.040 |
Why?
|
Radiography, Thoracic | 1 | 2001 | 322 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 1941 | 0.040 |
Why?
|
Nerve Net | 2 | 2017 | 374 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 102 | 0.040 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2020 | 115 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 922 | 0.040 |
Why?
|
Professional-Family Relations | 1 | 1999 | 54 | 0.040 |
Why?
|
Surveys and Questionnaires | 2 | 2018 | 2623 | 0.040 |
Why?
|
Time Management | 1 | 1998 | 9 | 0.040 |
Why?
|
Consumer Advocacy | 1 | 1998 | 10 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 1998 | 28 | 0.040 |
Why?
|
Time and Motion Studies | 1 | 1998 | 21 | 0.040 |
Why?
|
Drinking Behavior | 1 | 2018 | 13 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 1998 | 60 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 805 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 1998 | 118 | 0.040 |
Why?
|
Military Personnel | 1 | 2019 | 92 | 0.040 |
Why?
|
Heart Rate | 1 | 2020 | 495 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 1998 | 108 | 0.040 |
Why?
|
Health Care Surveys | 1 | 1998 | 280 | 0.040 |
Why?
|
Databases as Topic | 1 | 2017 | 94 | 0.040 |
Why?
|
Trauma Centers | 1 | 1998 | 146 | 0.040 |
Why?
|
Infusions, Intraventricular | 1 | 2017 | 5 | 0.040 |
Why?
|
Forecasting | 2 | 2016 | 306 | 0.040 |
Why?
|
Risk Factors | 2 | 2019 | 5498 | 0.040 |
Why?
|
Age of Onset | 1 | 2017 | 312 | 0.040 |
Why?
|
Europe | 1 | 2017 | 321 | 0.040 |
Why?
|
Inflammation | 1 | 2022 | 972 | 0.030 |
Why?
|
Down-Regulation | 1 | 2018 | 519 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2017 | 176 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 17 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 3448 | 0.030 |
Why?
|
Eating | 1 | 2017 | 166 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 787 | 0.030 |
Why?
|
United States | 2 | 2003 | 6987 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 314 | 0.030 |
Why?
|
Medication Adherence | 1 | 2017 | 140 | 0.030 |
Why?
|
Communication | 1 | 1999 | 459 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2018 | 378 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2022 | 2366 | 0.030 |
Why?
|
Neurology | 1 | 2016 | 74 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 860 | 0.030 |
Why?
|
Research Design | 1 | 1998 | 599 | 0.030 |
Why?
|
Area Under Curve | 1 | 2015 | 337 | 0.030 |
Why?
|
Gene Expression | 1 | 2018 | 1310 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2017 | 1072 | 0.030 |
Why?
|
Nitriles | 1 | 2014 | 160 | 0.030 |
Why?
|
Clinical Competence | 1 | 1998 | 784 | 0.030 |
Why?
|
Phenytoin | 1 | 2012 | 15 | 0.030 |
Why?
|
Phenobarbital | 1 | 2012 | 33 | 0.030 |
Why?
|
Philosophy, Medical | 1 | 1992 | 17 | 0.030 |
Why?
|
Industry | 1 | 1992 | 17 | 0.030 |
Why?
|
Aircraft | 1 | 1992 | 26 | 0.030 |
Why?
|
Transportation of Patients | 1 | 1992 | 32 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2017 | 2001 | 0.030 |
Why?
|
Drug Interactions | 1 | 2012 | 245 | 0.020 |
Why?
|
Program Development | 1 | 1992 | 123 | 0.020 |
Why?
|
Obesity | 1 | 2018 | 971 | 0.020 |
Why?
|
Regression Analysis | 1 | 2012 | 590 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 3666 | 0.020 |
Why?
|
Sex Factors | 1 | 2012 | 1066 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2008 | 32 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2008 | 66 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 1714 | 0.020 |
Why?
|
Semantics | 1 | 2008 | 48 | 0.020 |
Why?
|
Prospective Studies | 1 | 2015 | 4289 | 0.020 |
Why?
|
Motor Cortex | 1 | 2008 | 199 | 0.020 |
Why?
|
Electrocardiography | 1 | 2008 | 494 | 0.020 |
Why?
|
Brain Mapping | 1 | 2008 | 564 | 0.020 |
Why?
|
Doxycycline | 1 | 2004 | 28 | 0.020 |
Why?
|
Inhalation | 1 | 2004 | 31 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2004 | 125 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 6811 | 0.010 |
Why?
|
Radiography | 1 | 2004 | 809 | 0.010 |
Why?
|
Planning Techniques | 1 | 1992 | 10 | 0.010 |
Why?
|
Health Services Research | 1 | 1992 | 137 | 0.010 |
Why?
|
Data Collection | 1 | 1992 | 375 | 0.010 |
Why?
|